Announcement of the BOD approved removal of the non-compete clause for directors on behalf of major subsidiary Excelsior Asset Management Co., Ltd.

 

SEQ_NO  3 Date of announcement  2022/09/06 Time of announcement 17:01:28
Subject
Announcement of the BOD approved removal of the
non-compete clause for directors on behalf of major
subsidiary Excelsior Asset Management Co., Ltd.
Date of events 2022/09/06 To which item it meets paragraph 21
Statement
1.Date of the shareholders meeting resolution:2022/09/06
2.Name and title of the director with permission to 
  engage in competitive conduct:
  Director:Chang Hsien-Cheng
  Director:Fu Jo-Hsuan
  Director:Wang Ming-Ting
3.Items of competitive conduct in which the director is 
  permitted to engage:
  Concurrently serve as a director with the same or 
  similar business scope as the Company.
4.Period of permission to engage in the competitive 
  conduct: A director's term of office
5.Circumstances of the resolution (please describe the
  results of voting in accordance with Article 209 of 
  the Company Act): The board of directors approved the
  proposal unanimously.
  (In accordance with Article 128-1 of the Company Law, a 
  Company limited by shares which is organized by single 
  juristic person shareholder, the functional duties and 
  power of the shareholders' meeting shall be exercised by
  its board of directors)
6.If the permitted competitive conduct belongs to the 
  operator of a mainland China area enterprise, the name 
  and title of the directors (if it is not the operator of
  a Mainland-area enterprise, please enter “N/A” below):
  Director:Fu Jo-Hsuan
7.Company name of the mainland China area enterprise and 
  the director's position in the enterprise:
  Director of SinoExcelsior Investment Incorporation.
8.Address of the mainland China area enterprise:
  Room 301-2, No.1089, Kang Ning Lu, Shanghai Shi, China
9.Operations of the mainland China area enterprise:
  enterprise management consulting, business information 
  consulting,technical consulting and technical services 
  in the professional field of medical technology (except
  for the development and application of human stem cells,
  gene diagnosis and treatment technology), and wholesale
  of cosmetics, import and export,beauty-related shop,hair
  -related shop (limited to branch operations).
10.Impact on the company's finance and business:None.
11.If the directors have invested in the mainland China 
   area enterprise,the monetary amount of the investment 
   and their shareholding ratio:None.
12.Any other matters that need to be specified:
   In accordance with Article 128-1 of the Company Law,
   Excelsior Asset Management Co., Ltd. is held by one 
   single juristic person shareholder,the functional 
   duties and power of the Shareholders’Meeting shall be 
   exercised by its Board of Directors.